ArticleDiscover oncology2024

Enhancing antitumor activity of herceptin in HER2-positive breast cancer cells: a novel DNMT-1 inhibitor approach.

Li-Li Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.